Study: Social Impact of Emerging Technologies – National Science Foundation awards more than $ 12.5 millionThe National Science Foundation recently renewed two important cooperative agreements totaling more than $ 12,000 over five years. These awards use existing investments for research into the ethical, legal, economic and political effects of the relatively new, nature-altering science called nanotechnology.
– As part of the National Nanotechnology Initiative, the responsible development identified as one of four strategic goals for nanotechnology research, NSF committed to investigating the social aspects of this promising but uncertain technology. These centers play a crucial role in understanding and anticipating the potential societal impacts of nanotechnology and engaging multiple stakeholders in the discussions on the future of new technologies, said Myron Gutmann, NSF assistant director of Social Behavioral and Economic Sciences. They are truly interdisciplinary centers, spanning the social, natural and engineering sciences. Continue reading
By the Canadian by the Canadian Institutes of Health Research.Kimmelman and London are currently the quality and the results of studies such as drug card from preclinical phases of the study, clinical trials thanks to a recent grant from the Canadian Institutes of Health Research. levitra-portugal.com/comentarios.html
Ethicists Outline Ways To Risk / Benefit Estimates in New Drug Trials EnhanceIt’s all too familiar: researchers are discovering a new drug that eliminates disease in animals. A few years later, the drug bombs in human trials. In the latest issue of the journal PLoS Medicine, argue ethics experts Jonathan Kimmelman, associate professor of the biomedical ethics McGill Unit and Department of Social Studies of Medicine, and Alex John London, associate professor of philosophy at Carnegie Mellon University found that this pattern of boom of and bust, the way researchers predict outcomes of their work are in the early stages of drug development. ‘We a pretty good job a pretty good job of predicting the success of interventions that make it to the later stages of clinical research,’said London, who also directs CMU Center for Ethics and Politics. ‘But when it comes to the leap from animal studies to the first trials in humans, there are serious problems. ‘. Continue reading